Starting treatment earlier does not appear to worsen the course of Parkinson’s disease or be associated with more severe treatment…
Articles by Marisa Wexler, MS
People who are infected with SARS-CoV2 — the virus that causes COVID-19 — may be at greater risk of…
The U.S. Food and Drug Administration (FDA) has named  Cala Trio a breakthrough device as a potential wrist-worn treatment of action tremors in…
Sanofi will provide $1 million in research funding over the next two years to support PD GENEration, a…
Rodent neurons (nerve cells) in cell cultures form complex interaction networks that seem designed to maximize information processing, but are…
Targeting certain regions of the alpha-synuclein protein could be a viable therapeutic strategy for Parkinson’s disease, a study suggests.
The investigational gene therapy AXO-Lenti-PD continues to be well-tolerated and to ease disease symptoms in people with Parkinson’s, new…
Oral Ongentys (opicapone) as a daily add-on treatment shortened overnight “off” periods and eased dyskinesia during “on” periods in people…
Ongentys (opicapone) can reduce the extent of “off” periods in people with Parkinson’s disease being treated with  levodopa,…
Spinal cord stimulation can effectively decrease pain, and also may help alleviate motor symptoms, in people with Parkinson’s disease…